JEPIX
Price
$14.17
Change
+$0.03 (+0.21%)
Updated
Jul 3 closing price
Net Assets
6.43B
PRRCX
Price
$12.40
Change
+$0.05 (+0.40%)
Updated
Jul 3 closing price
Net Assets
129.62M
Interact to see
Advertisement

JEPIX vs PRRCX

Header iconJEPIX vs PRRCX Comparison
Open Charts JEPIX vs PRRCXBanner chart's image
JPMorgan Equity Premium Income I
Price$14.17
Change+$0.03 (+0.21%)
VolumeN/A
Net Assets6.43B
Victory Pioneer Equ Premium Income C
Price$12.40
Change+$0.05 (+0.40%)
VolumeN/A
Net Assets129.62M
JEPIX vs PRRCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JEPIX vs. PRRCX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JEPIX is a Buy and PRRCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JEPIX has more cash in the bank: 6.43B vs. PRRCX (130M). PRRCX pays higher dividends than JEPIX: PRRCX (10.86) vs JEPIX (8.28). JEPIX was incepted earlier than PRRCX: JEPIX (7 years) vs PRRCX (15 years). PRRCX (2.14) is less costly to investors than JEPIX (0.60). JEPIX is a more actively managed with annual turnover of: 176.00 vs. PRRCX (114.00). PRRCX has a lower initial minimum investment than JEPIX: PRRCX (1000) vs JEPIX (1000000). PRRCX annual gain was more profitable for investors over the last year : 11.17 vs. JEPIX (9.75). JEPIX return over 5 years is better than : 71.19 vs. PRRCX (33.11).
JEPIXPRRCXJEPIX / PRRCX
Total Expense Ratio0.602.1428%
Annual Report Gross Expense Ratio0.602.1428%
Fund Existence7 years15 years-
Gain YTD3.14710.54030%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.43B130M4,948%
Annual Yield % from dividends8.2810.8676%
Returns for 1 year9.7511.1787%
Returns for 3 years32.5628.78113%
Returns for 5 years71.1933.11215%
Returns for 10 yearsN/A17.67-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGOAX41.250.42
+1.03%
Patient Opportunity A
TARKX30.490.31
+1.03%
Tarkio
MMMPX24.740.14
+0.57%
Morgan Stanley Inst Emerging Mkts R6
VGIFX88.660.48
+0.54%
JPMorgan US Value R5
EILAX14.01-0.02
-0.14%
Eaton Vance International Small-Cap A